{"id":160690,"date":"2014-11-21T07:46:35","date_gmt":"2014-11-21T12:46:35","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/veterinary-pharmacology-research-foundation-continues-support-for-american-college-of-veterinary-internal-medicine.php"},"modified":"2014-11-21T07:46:35","modified_gmt":"2014-11-21T12:46:35","slug":"veterinary-pharmacology-research-foundation-continues-support-for-american-college-of-veterinary-internal-medicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/veterinary-pharmacology-research-foundation-continues-support-for-american-college-of-veterinary-internal-medicine.php","title":{"rendered":"Veterinary Pharmacology Research Foundation Continues Support for American College of Veterinary Internal Medicine"},"content":{"rendered":"<p><p>Contact Information         <\/p>\n<p>      Available for logged-in reporters only    <\/p>\n<p>    Newswise  Denver, Colorado -- The American College of    Veterinary Internal Medicine Foundation (ACVIMF), in    partnership with the Veterinary Pharmacology Research    Foundation (VPRF), announced today that they have funded a new    study for animal health with a pharmacologic focus. The study    will be conducted by Dr. Lauren Trepanier of the University of    Wisconsin-Madison for the Genetic risk for cyclophosphamide    toxicity in dogs.  <\/p>\n<p>    The strategic partnership between VPRF and ACVIMF began in 2009    in an effort to solicit, review and administer research grants    with a pharmacologic focus. The Veterinary Pharmacology    Research Foundation (VPRF) was formed by the governing bodies    of American Academy of Veterinary Pharmacology and Therapeutics    (AAVPT) and the American College of Veterinary Clinical    Pharmacology (ACVCP) in June of 2006. These organizations    recognized that the lack of funding for basic pharmacology    research was limiting both growth and innovation in the    development of new veterinary therapeutics and the number of    trained researchers in the field. As such, they sought to    invest their collective resources in the growth of veterinary    pharmacology through research grants and training programs.    Jane Owens, President, VPRF.  <\/p>\n<p>    The first call for proposals went out in November 2009. Since    then, the partnership has awarded over $88,250 to six ACVIM    Board-certified researchers along with their research team    members. The first VPRF grant was awarded in June 2010 to Drs.    Kenneth Simpson, Melanie Craven and Belgin Dogan from Cornell    University for the development of a novel amikacin delivery    method for treatment of E. coli associated with Granulomatous    Colitis of Boxer dogs.  <\/p>\n<p>    In 2011, the second grant was awarded to Drs. Butch KuKanich    and Kate KuKanich from Kansas State University for a study to    determine the effect of CYP inhibition on tramadol    disposition and pharmacological effects in dogs. In 2012,    Drs. Chen Gilor and Christopher Adin of the Veterinary Clinical    Sciences Department at the Ohio State University received    funding for evaluating Exenatide extended release in    cats. Grant monies were also awarded to Drs. Jennifer    Myers, Janice Bright, Christopher Orton, Daniel Gustafson and    Christine Swardson Olver from the College of Veterinary    Medicine & Biomedical Sciences, Colorado State University    for evaluation of the pharmacokinetics and pharmacodynamics    of Apibaxin in cats. The 2013 VPRF funds were awarded to    Dr. Dawn Boothe and resident Jacqueline Gimmler of Auburn    University for establishing terbinafine doses for treatment    of canine Malassezia infection.  <\/p>\n<p>    The grants encourage investigators to submit proposals that    focus on research to evaluate the safety, effectiveness and    duration of effect of therapies for veterinary species, explore    new drug therapies for animals, develop and validate methods of    evaluating effects of drugs in animal diseases or conditions,    or ensure that a safe food supply is not compromised by drug    therapy. As this grant is a partnership between veterinary    internists and VPRF, collaborations between pharmacologists and    Diplomates of ACVIM were strongly encouraged.  <\/p>\n<p>    About Veterinary Pharmacology Research Foundation    The Veterinary Pharmacology Research Foundation provides grant    funding to support research into new and currently approved    medications for combating diseases of companion and food    animals, projects that ensure the safety of food products from    treated livestock, and training programs for veterinary    pharmacologists. These areas have been unmet needs in    veterinary medicine for over 30 years. To donate to the    Foundation, please access the following: <a href=\"http:\/\/aavpt.affiniscape.com\/associations\/12658\/files\/VPRFDonationForm3.pdf\" rel=\"nofollow\">http:\/\/aavpt.affiniscape.com\/associations\/12658\/files\/VPRFDonationForm3.pdf<\/a>  <\/p>\n<p>    About the ACVIM Foundation    The American College of Veterinary Internal Medicine (ACVIM)    Foundation is a non-profit 501(c)(3) organization dedicated to    pioneering the healthcare of animals through the work of    specialists in the American College of Veterinary Internal    Medicine (ACVIM): small and large animal internists,    cardiologists, neurologists, and oncologists. By supporting the    work of these groundbreaking scientists, by raising awareness    of specialty medicine, and by mobilizing the animal-loving    public, we aim to revolutionize current treatments and spark    the discovery of future cures. The ACVIM Foundation recognizes    the need for advanced care, research dollars, awareness, and    the need to support the Resident-in-training and the future    scientist. Learn more at <a href=\"http:\/\/www.ACVIMFoundation.org\" rel=\"nofollow\">http:\/\/www.ACVIMFoundation.org<\/a>.  <\/p>\n<p>    # # #<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/626438\/?sc=rsmn\/RK=0\/RS=_7ytolLOsPaQSq0a7mLdXiBT.t4-\" title=\"Veterinary Pharmacology Research Foundation Continues Support for American College of Veterinary Internal Medicine\">Veterinary Pharmacology Research Foundation Continues Support for American College of Veterinary Internal Medicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Contact Information Available for logged-in reporters only Newswise Denver, Colorado -- The American College of Veterinary Internal Medicine Foundation (ACVIMF), in partnership with the Veterinary Pharmacology Research Foundation (VPRF), announced today that they have funded a new study for animal health with a pharmacologic focus. The study will be conducted by Dr. Lauren Trepanier of the University of Wisconsin-Madison for the Genetic risk for cyclophosphamide toxicity in dogs.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/veterinary-pharmacology-research-foundation-continues-support-for-american-college-of-veterinary-internal-medicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-160690","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/160690"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=160690"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/160690\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=160690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=160690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=160690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}